234 related articles for article (PubMed ID: 30646224)
1. Assessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification.
Sreekumar R; Harris S; Moutasim K; DeMateos R; Patel A; Emo K; White S; Yagci T; Tulchinsky E; Thomas G; Primrose JN; Sayan AE; Mirnezami AH
JAMA Netw Open; 2018 Oct; 1(6):e183115. PubMed ID: 30646224
[TBL] [Abstract][Full Text] [Related]
2. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
3. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
[TBL] [Abstract][Full Text] [Related]
4. The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer.
Sreekumar R; Al-Saihati H; Emaduddin M; Moutasim K; Mellone M; Patel A; Kilic S; Cetin M; Erdemir S; Navio MS; Lopez MA; Curtis N; Yagci T; Primrose JN; Price BD; Berx G; Thomas GJ; Tulchinsky E; Mirnezami A; Sayan AE
Mol Oncol; 2021 Aug; 15(8):2065-2083. PubMed ID: 33931939
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
[TBL] [Abstract][Full Text] [Related]
7. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
Chen DL; Lu YX; Zhang JX; Wei XL; Wang F; Zeng ZL; Pan ZZ; Yuan YF; Wang FH; Pelicano H; Chiao PJ; Huang P; Xie D; Li YH; Ju HQ; Xu RH
Theranostics; 2017; 7(19):4836-4849. PubMed ID: 29187907
[TBL] [Abstract][Full Text] [Related]
9. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K
BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
[No Abstract] [Full Text] [Related]
11. Tumoral and stromal expression of Slug, ZEB1, and ZEB2 in brain metastasis.
Nagaishi M; Nakata S; Ono Y; Hirata K; Tanaka Y; Suzuki K; Yokoo H; Hyodo A
J Clin Neurosci; 2017 Dec; 46():124-128. PubMed ID: 28890036
[TBL] [Abstract][Full Text] [Related]
12. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer.
Fan XJ; Wan XB; Fu XH; Wu PH; Chen DK; Wang PN; Jiang L; Wang DH; Chen ZT; Huang Y; Wang JP; Wang L
Tumour Biol; 2014 Oct; 35(10):10487-95. PubMed ID: 25056534
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer.
Haro GJ; Sheu B; Cook NR; Woodard GA; Mann MJ; Kratz JR
JAMA Netw Open; 2019 Dec; 2(12):e1917062. PubMed ID: 31808928
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.
Cai MY; Luo RZ; Chen JW; Pei XQ; Lu JB; Hou JH; Yun JP
PLoS One; 2012; 7(2):e32838. PubMed ID: 22393452
[TBL] [Abstract][Full Text] [Related]
17. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
18. Overexpression of G protein-coupled receptor 31 as a poor prognosticator in human colorectal cancer.
Rong YM; Huang XM; Fan DJ; Lin XT; Zhang F; Hu JC; Tan YX; Chen X; Zou YF; Lan P
World J Gastroenterol; 2018 Nov; 24(41):4679-4690. PubMed ID: 30416315
[TBL] [Abstract][Full Text] [Related]
19. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer.
Jiang H; Tang E; Xu D; Chen Y; Zhang Y; Tang M; Xiao Y; Zhang Z; Deng X; Li H; Lin M
Oncotarget; 2017 May; 8(18):29857-29864. PubMed ID: 28415740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
